Serum McA, CA 125 and CA 19.9 Determination in Primary Breast Cancer

Biochemical Society Transactions - United Kingdom
doi 10.1042/bst024302s
Full Text
Abstract

Available in full text

Categories
Biochemistry
Date
Authors
Publisher

Portland Press Ltd.

Related search

CA 19-9 and CA 125 Determination by Immunoluminometric Assay

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
1990English

Luminoimmunometric Assay of Tissue Polypeptide Antigen (Tpa) and Cancer Antigen 125 (Ca-125) in Breast Cancer Patients

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
1993English

Monitoring Ovarian Carcinoma With CA 125, CA 19–9, CA 15–3 and CEA in Serum, Ascites and Tumor Tissue

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Tag-72, CA 19.9 and CEA as Tumor Markers in Gastric Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1994English

Significance of the Serum CA-125 Level in Intrauterine Insemination Cycles

Clinical and Experimental Reproductive Medicine
Reproductive Medicine
2011English

Causes of Elevated Levels of Serum CA 19.9 in Patients Without Prior Diagnosis of Malignant Disease

Southern Clinics of Istanbul Eurasia
2019English

The Role of CA‐125 in the Management of Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Risk of Diagnosis of Ovarian Cancer After Raised Serum CA 125 Concentration: A Prospective Cohort Study

BMJ
1996English

CA-125 Secreting IgG Kappa Multiple Myeloma

American Journal of Hematology
Hematology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy